Marigo, Ilaria
Zilio, Serena
Desantis, Giacomo
Mlecnik, Bernhard
Agnellini, Andrielly H.R.
Ugel, Stefano
Sasso, Maria Stella
Qualls, Joseph E.
Kratochvill, Franz
Zanovello, Paola
Molon, Barbara
Ries, Carola H.
Runza, Valeria
Hoves, Sabine
Bilocq, Amélie M.
Bindea, Gabriela
Mazza, Emilia M.C.
Bicciato, Silvio
Galon, Jérôme
Murray, Peter J.
Bronte, Vincenzo
Funding for this research was provided by:
Italian Ministry of Health (E35G1400019001)
Italian Ministry of Education Universities, and Research (B31J11000420001, RBAP11T3WB)
Italian Flagship Project Epigenomics
Italian Association for Cancer Research (6599, 12182, 14103)
PRIN 2009 (2009NREAT2_003)
National Cancer Institute of France
INSERM
Cancer Research For Personalized Medicine
Paris Alliance of Cancer Research Institutes
NIH (CA189990, CA138064)
Alex's Lemonade Stand Foundation
Hartwell Foundation
Cancer Center Core (P30 CA21765)
Austrian Science Fund (J3309-B19)
American Lebanese Syrian Associated Charities
Cariparo Foundation
This article is maintained by: Elsevier
Article Title: T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells
Journal Title: Cancer Cell
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.ccell.2016.08.004
Content Type: article
Copyright: © 2016 Elsevier Inc.